Surgical Tourniquets Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Tourniquet Systems, Tourniquet Cuffs, Non-Pneumatic Tourniquet Cuffs, and Tourniquet Accessories), By Application (Arthroplasty, Amputation of limbs, Plastic Surgeries, and Trauma Cases), By End-User (Hospitals and Trauma Centers, Ambulatory Surgery Centers, Military, and  Others), and Region Forecast 2019-2030

Surgical Tourniquets Market size was valued at US$ 474.6 million in 2023 and is projected to reach a value of US$ 792.5 million by 2030, at a CAGR of 7.6% from 2024-2030. Moreover, the U.S. surgical tourniquets market is projected to grow significantly, reaching an estimated value of US$ 318.4 million by 2032.

Increasing requirements for tourniquets in military usage, rapid growth in R&D activity, technological innovation such as sterile disposable tourniquets, government initiatives, and increased cases of intestinal-related disorders are driving the market. However, the lack of product differentiation and side effects after using tourniquets such as hyperemia, hyperthermia, and pain limit the market growth. In addition, latex-free tourniquets and many programs and initiatives undertaken by the government are now promoting healthy development for the market.

Key Players

Key players in the surgical tourniquets market include Stryker Corporation, Johnson & Johnson, Medtronic, Zimmer Biomet, Teleflex Incorporated, Halyard Health, and Smith & Nephew. Also, a comprehensive analysis of industry verticals and market participants that provides a clear overview of the competitive landscape in relation to the sectors served by the company’s products and services, market share, service offerings, financial reports, significant developments, market strategy, competitive position, and geographic reach

Key Takeaways

• The Asia-Pacific region is currently the most rapidly expanding market for surgical tourniquets
• The largest region in the market in North America
• Based on the type, tourniquet systems segment holds a 42.7% market share
• Based on the application, arthroplasty segment holds a 28.4% market share
• Based on the End-User Hospitals and Trauma Centers segment holds 31.8% market share
• By April 2024, the number of registered medical device companies producing tourniquets in the Asia-Pacific region had increased by 40% compared to the previous year
• In May 2024, a report indicated that 75% of surgeons preferred customizable tourniquet solutions to cater to specific patient needs

Facts & Figures

• As of January 2024, 80% of surgical facilities in Europe reported plans to upgrade their tourniquet systems within the next two years.
• In February 2024, a study revealed that the integration of monitoring technology in tourniquets reduced complication rates by 30% in surgeries.
• In October 2023, a survey indicated that 65% of orthopedic surgeons in North America use single-use tourniquets to reduce infection risks.

Key Developments

• In March 2023: Zimmer Biomet announced the acquisition of a startup focused on innovative tourniquet technologies, expanding its product portfolio
• In August 2023: Halyard Health launched a new line of disposable tourniquets aimed at increasing infection control in surgical environments.
• In September 2022: Stryker Corporation introduced a next-generation digital tourniquet system, featuring enhanced monitoring capabilities.

Surgical Tourniquets Market Segmentation

By Type: Under surgical tourniquets, the market leader is tourniquet systems, which cover the advanced technology integration aspect that supports and enhances both efficiency and safety during surgery. The uptake is caused by the rise in demand for it from facilities wanting to prevent complications associated with surgeries. Tourniquet cuffs-Pneumatic Tourniquet Cuffs, particularly single are storming the industry since they become convenient, lowering the probability of infections as well as contributing to the overall trend in the market.

By Application: The leading application in the market is the Arthroplasty. This is an application led by the massive volume of orthopedic surgeries yearly. This is an essential segment as most joint replacement procedures require adequate hemostasis. Immediately after this comes the Trauma Cases. The reason here is that these tourniquets have become of extreme importance to managing uncontrolled bleeding due to traumas in emergency medical settings

By End-User: Hospitals and Trauma Centers are the largest segment of the market as a primary end-user. This is due to the increasing number of surgeries and emergency procedures carried out in hospitals and trauma centers. Hospitals will require highly advanced tourniquet systems to protect patients' safety and prevent excessive blood loss during surgical procedures. Ambulatory Surgery Centers are also rising due to an increased volume of outpatient procedures. The military is one of the biggest niche markets with specific solutions applied in cases of combat and emergency medical situations.